ARS Pharmaceuticals (SPRY) Total liabilities

annual total liabilities:

$94.36M+$91.93M(+3786.12%)
December 31, 2024

Summary

  • As of today (June 25, 2025), SPRY annual total liabilities is $94.36 million, with the most recent change of +$91.93 million (+3786.12%) on December 31, 2024.
  • During the last 3 years, SPRY annual total liabilities has risen by +$1.64 million (+1.77%).
  • SPRY annual total liabilities is now at all-time high.

Performance

SPRY Total liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSPRYbalance sheet metrics

quarterly total liabilities:

$98.34M+$3.99M(+4.23%)
March 31, 2025

Summary

  • As of today (June 25, 2025), SPRY quarterly total liabilities is $98.34 million, with the most recent change of +$3.99 million (+4.23%) on March 31, 2025.
  • Over the past year, SPRY quarterly total liabilities has increased by +$94.63 million (+2547.21%).
  • SPRY quarterly total liabilities is now at all-time high.

Performance

SPRY quarterly total liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSPRYbalance sheet metrics

Total liabilities Formula

Total Liabilities = Current Liabilities + Long-Term Liabilities

SPRY Total liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+3786.1%+2547.2%
3 y3 years+1.8%-
5 y5 years+133.2%+6.1%

SPRY Total liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+3786.1%at high+3950.4%
5 y5-yearat high+3786.1%at high+3950.4%
alltimeall timeat high+3786.1%at high+3950.4%

SPRY Total liabilities History

DateAnnualQuarterly
Mar 2025
-
$98.34M(+4.2%)
Dec 2024
$94.36M(+3786.1%)
$94.36M(+467.6%)
Sep 2024
-
$16.62M(+147.2%)
Jun 2024
-
$6.72M(+81.0%)
Mar 2024
-
$3.71M(+53.0%)
Dec 2023
$2.43M
$2.43M(-78.5%)
Sep 2023
-
$11.27M(+10.5%)
DateAnnualQuarterly
Jun 2023
-
$10.20M(+1.6%)
Mar 2023
-
$10.04M(+17.4%)
Dec 2022
$8.55M(-90.8%)
$8.55M(-90.5%)
Jun 2022
-
$90.08M(-2.8%)
Dec 2021
$92.72M(+129.2%)
-
Dec 2021
-
$92.72M
Dec 2020
$40.46M
-

FAQ

  • What is ARS Pharmaceuticals annual total liabilities?
  • What is the all time high annual total liabilities for ARS Pharmaceuticals?
  • What is ARS Pharmaceuticals annual total liabilities year-on-year change?
  • What is ARS Pharmaceuticals quarterly total liabilities?
  • What is the all time high quarterly total liabilities for ARS Pharmaceuticals?
  • What is ARS Pharmaceuticals quarterly total liabilities year-on-year change?

What is ARS Pharmaceuticals annual total liabilities?

The current annual total liabilities of SPRY is $94.36M

What is the all time high annual total liabilities for ARS Pharmaceuticals?

ARS Pharmaceuticals all-time high annual total liabilities is $94.36M

What is ARS Pharmaceuticals annual total liabilities year-on-year change?

Over the past year, SPRY annual total liabilities has changed by +$91.93M (+3786.12%)

What is ARS Pharmaceuticals quarterly total liabilities?

The current quarterly total liabilities of SPRY is $98.34M

What is the all time high quarterly total liabilities for ARS Pharmaceuticals?

ARS Pharmaceuticals all-time high quarterly total liabilities is $98.34M

What is ARS Pharmaceuticals quarterly total liabilities year-on-year change?

Over the past year, SPRY quarterly total liabilities has changed by +$94.63M (+2547.21%)
On this page